Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression

doi:10.1084/jem.157.3.1040

This Article

	Full Text (PDF, 909K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Uyttenhove, C.
	Articles by Boon, T.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Uyttenhove, C.
	Articles by Boon, T.

Social Bookmarking

	What's this?

ARTICLES

Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression

C Uyttenhove, J Maryanski and T Boon

Even though mastocytoma P815 often undergoes a nearly complete rejection in syngeneic mice, the tumor cells almost always escape to form progressive tumors. We found that this was not due to the establishment of an immunosuppressed state because genetically marked P815 cells, that were injected in mice where tumor escape was occurring, were readily rejected. An analysis of escaping tumor cell populations with anti-P815 cytolytic T lymphocyte (CTL) clones showed the presence of stable resistant variants. Using antigen-loss variants found in escaping populations or selected in vitro with CTL clones, we were able to define four different tumor-associated antigenic specificities, each recognized by a specific CTL clone. One of these specificities was absent from all escaping tumor cells and another had been lost by some of them.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Shanker, A., Verdeil, G., Buferne, M., Inderberg-Suso, E.-M., Puthier, D., Joly, F., Nguyen, C., Leserman, L., Auphan-Anezin, N., Schmitt-Verhulst, A.-M. (2007). CD8 T Cell Help for Innate Antitumor Immunity. J. Immunol. 179: 6651-6662 [Abstract] [Full Text]
Naslund, T. I., Uyttenhove, C., Nordstrom, E. K. L., Colau, D., Warnier, G., Jondal, M., Van den Eynde, B. J., Liljestrom, P. (2007). Comparative Prime-Boost Vaccinations Using Semliki Forest Virus, Adenovirus, and ALVAC Vectors Demonstrate Differences in the Generation of a Protective Central Memory CTL Response against the P815 Tumor. J. Immunol. 178: 6761-6769 [Abstract] [Full Text]
Bai, X.-F., Liu, J.-Q., Joshi, P. S., Wang, L., Yin, L., Labanowska, J., Heerema, N., Zheng, P., Liu, Y. (2006). Different Lineages of P1A-Expressing Cancer Cells Use Divergent Modes of Immune Evasion for T-Cell Adoptive Therapy. Cancer Res. 66: 8241-8249 [Abstract] [Full Text]
Liu, K., Caldwell, S. A., Greeneltch, K. M., Yang, D., Abrams, S. I. (2006). CTL Adoptive Immunotherapy Concurrently Mediates Tumor Regression and Tumor Escape. J. Immunol. 176: 3374-3382 [Abstract] [Full Text]
Yu, P., Lee, Y., Liu, W., Krausz, T., Chong, A., Schreiber, H., Fu, Y.-X. (2005). Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. JEM 201: 779-791 [Abstract] [Full Text]
Lurquin, C., Lethe, B., De Plaen, E., Corbiere, V., Theate, I., van Baren, N., Coulie, P. G., Boon, T. (2005). Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen. JEM 201: 249-257 [Abstract] [Full Text]
Radhakrishnan, S., Nguyen, L. T., Ciric, B., Flies, D., Keulen, V. P. V., Tamada, K., Chen, L., Rodriguez, M., Pease, L. R. (2004). Immunotherapeutic Potential of B7-DC (PD-L2) Cross-Linking Antibody In Conferring Antitumor Immunity. Cancer Res. 64: 4965-4972 [Abstract] [Full Text]
Tahara, H., Fujio, K., Araki, Y., Setoguchi, K., Misaki, Y., Kitamura, T., Yamamoto, K. (2003). Reconstitution of CD8+ T Cells by Retroviral Transfer of the TCR {alpha}{beta}-Chain Genes Isolated from a Clonally Expanded P815-Infiltrating Lymphocyte. J. Immunol. 171: 2154-2160 [Abstract] [Full Text]
Matsui, K., O'Mara, L. A., Allen, P. M. (2003). Successful elimination of large established tumors and avoidance of antigen-loss variants by aggressive adoptive T cell immunotherapy. Int Immunol 15: 797-805 [Abstract] [Full Text]
Nagarajan, S., Selvaraj, P. (2002). Glycolipid-anchored IL-12 Expressed on Tumor Cell Surface Induces Antitumor Immune Response. Cancer Res. 62: 2869-2874 [Abstract] [Full Text]
Wang, J., Shaw, J. L., Mullen, C. A. (2002). Down-Regulation of Antihost Alloreactivity after Bone Marrow Transplant Permits Relapse of Hematological Malignancy. Cancer Res. 62: 208-212 [Abstract] [Full Text]
Beck-Engeser, G. B., Monach, P. A., Mumberg, D., Yang, F., Wanderling, S., Schreiber, K., Espinosa, R. III, Le Beau, M. M., Meredith, S. C., Schreiber, H. (2001). Point Mutation in Essential Genes with Loss or Mutation of the Second Allele: Relevance to the Retention of Tumor-Specific Antigens. JEM 194: 285-300 [Abstract] [Full Text]
Markiewicz, M. A., Fallarino, F., Ashikari, A., Gajewski, T. F. (2001). Epitope spreading upon P815 tumor rejection triggered by vaccination with the single class I MHC-restricted peptide P1A. Int Immunol 13: 625-632 [Abstract] [Full Text]
Zheng, H., Palese, P., García-Sastre, A. (2000). Antitumor Properties of Influenza Virus Vectors. Cancer Res. 60: 6972-6976 [Abstract] [Full Text]
Fallarino, F., Grohmann, U., Bianchi, R., Vacca, C., Fioretti, M. C., Puccetti, P. (2000). Th1 and Th2 Cell Clones to a Poorly Immunogenic Tumor Antigen Initiate CD8+ T Cell-Dependent Tumor Eradication In Vivo. J. Immunol. 165: 5495-5501 [Abstract] [Full Text]
Anderson, L. D. Jr., Mori, S., Mann, S., Savary, C. A., Mullen, C. A. (2000). Pretransplant Tumor Antigen-specific Immunization of Allogeneic Bone Marrow Transplant Donors Enhances Graft-versus-Tumor Activity without Exacerbation of Graft-versus-Host Disease. Cancer Res. 60: 5797-5802 [Abstract] [Full Text]
Haicheur, N., Bismuth, E., Bosset, S., Adotevi, O., Warnier, G., Lacabanne, V., Regnault, A., Desaymard, C., Amigorena, S., Ricciardi-Castagnoli, P., Goud, B., Fridman, W. H., Johannes, L., Tartour, E. (2000). The B Subunit of Shiga Toxin Fused to a Tumor Antigen Elicits CTL and Targets Dendritic Cells to Allow MHC Class I-Restricted Presentation of Peptides Derived from Exogenous Antigens. J. Immunol. 165: 3301-3308 [Abstract] [Full Text]
Guttinger, M., Guidi, F., Chinol, M., Reali, E., Veglia, F., Viale, G., Paganelli, G., Corti, A., Siccardi, A. G. (2000). Adoptive Immunotherapy by Avidin-driven Cytotoxic T Lymphocyte- Tumor Bridging. Cancer Res. 60: 4211-4215 [Abstract] [Full Text]
Sturmhoefel, K., Lee, K., Gray, G. S., Thomas, J., Zollner, R., O'Toole, M., Swiniarski, H., Dorner, A., Wolf, S. F. (1999). Potent Activity of Soluble B7-IgG Fusion Proteins in Therapy of Established Tumors and as Vaccine Adjuvant. Cancer Res. 59: 4964-4972 [Abstract] [Full Text]
Grohmann, U., Bianchi, R., Belladonna, M. L., Vacca, C., Silla, S., Ayroldi, E., Fioretti, M. C., Puccetti, P. (1999). IL-12 Acts Selectively on CD8{alpha}- Dendritic Cells to Enhance Presentation of a Tumor Peptide In Vivo. J. Immunol. 163: 3100-3105 [Abstract] [Full Text]
Zheng, P., Sarma, S., Guo, Y., Liu, Y. (1999). Two Mechanisms for Tumor Evasion of Preexisting Cytotoxic T-Cell Responses: Lessons from Recurrent Tumors. Cancer Res. 59: 3461-3467 [Abstract] [Full Text]
Matsui, S., Ahlers, J. D., Vortmeyer, A. O., Terabe, M., Tsukui, T., Carbone, D. P., Liotta, L. A., Berzofsky, J. A. (1999). A Model for CD8+ CTL Tumor Immunosurveillance and Regulation of Tumor Escape by CD4 T Cells Through an Effect on Quality of CTL. J. Immunol. 163: 184-193 [Abstract] [Full Text]
Evans, T.R.J., Kaye, S.B. (1999). Vaccine therapy for cancer�fact or fiction?. QJM 92: 299-307 [Full Text]
Matsuo, M., Wada, H., Honda, S., Tawara, I., Uenaka, A., Kanematsu, T., Nakayama, E. (1999). Expression of Multiple Unique Rejection Antigens on Murine Leukemia BALB/c RL[IMAGE]1 and the Role of Dominant Akt Antigen for Tumor Escape. J. Immunol. 162: 6420-6425 [Abstract] [Full Text]
Bilsborough, J., Van Pel, A., Uyttenhove, C., Boon, T., Van den Eynde, B. J. (1999). Identification of a Second Major Tumor-Specific Antigen Recognized by CTLs on Mouse Mastocytoma P815. J. Immunol. 162: 3534-3540 [Abstract] [Full Text]
Sarma, S., Guo, Y., Guilloux, Y., Lee, C., Bai, X.-F., Liu, Y. (1999). Cytotoxic T Lymphocytes to An Unmutated Tumor Rejection Antigen P1A: Normal Development but Restrained Effector Function In Vivo. JEM 189: 811-820 [Abstract] [Full Text]
Groux, H., Cottrez, F., Rouleau, M., Mauze, S., Antonenko, S., Hurst, S., McNeil, T., Bigler, M., Roncarolo, M.-G., Coffman, R. L. (1999). A Transgenic Model to Analyze the Immunoregulatory Role of IL-10 Secreted by Antigen-Presenting Cells. J. Immunol. 162: 1723-1729 [Abstract] [Full Text]
Fernandez, N. C., Levraud, J.-P., Haddada, H., Perricaudet, M., Kourilsky, P. (1999). High Frequency of Specific CD8+ T Cells in the Tumor and Blood Is Associated with Efficient Local IL-12 Gene Therapy of Cancer. J. Immunol. 162: 609-617 [Abstract] [Full Text]
Boon, T., Van den Eynde, B., Hirsch, H., Moroni, C., De Plaen, E., van der Bruggen, P., De Smet, C., Lurquin, C., Szikora, J.-P., De Backer, O. (1994). Genes Coding for Tumor-specific Rejection Antigens. Cold Spring Harb Symp Quant Biol 59: 617-622 [Abstract]
van der Bruggen, P, Traversari, C, Chomez, P, Lurquin, C, De Plaen, E, Van den Eynde, B, Knuth, A, Boon, T (1991). A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643-1647 [Abstract]
Boon, T., Van Pel, A., De Plaen, E., Chomez, P., Lurquin, C., Szikora, J.-P, Sibille, C., Mariame, B., Van den Eynde, B., Lethe, B., Brichart, V. (1989). Genes Coding for T-cell-defined Tum Transplantation Antigens: Point Mutations, Antigenic Peptides, and Subgenic Expression. Cold Spring Harb Symp Quant Biol 54: 587-596 [Abstract]